ADVISORY BOARD

Samir Courdy is the Senior Vice President of Informatics for City of Hope Cancer Center. He is a proven leader in building enterprise scale software solutions for biotech and cancer centers, most notably POSEIDON, a next generation real world data and evidence RWD&E informatics insights platform for precision medicine research and discovery, which has been in use at City of Hope for more than three years.

Rayna Herman is Chief Commercial Officer with Shorla Oncology. She specializes in developing commercial strategies for growth and has launched more than 20 products in her 30+ year career in life sciences. She previously served as a CCO with EVERSANA and as a Principal of Health Strategies Group where she successfully positioned the company for sale to private equity.

Dr. Graham Hughes is a serial entrepreneur with over 30 years of digital healthcare and life sciences market experience in analytics and AI-powered solutions. His previous roles include President and Chief Operating Officer of Saykara; Chief Executive Officer of Sutherland Healthcare; Chief Medical Officer and Head of Innovation at SAS Analytics; and Vice President of Global Product Strategy at GE Healthcare.

Dr. Adrian Lee is the Pittsburgh Foundation Chair and Director of the Institute for Precision Medicine, a joint effort by the University of Pittsburgh and UPMC to move biomedical research into personalized well-being and clinical care. He is also a Professor of Pharmacology & Chemical Biology and Human Genetics at the University of Pittsburgh and UPMC Hillman Cancer Center.

Dr. David Miller is an accomplished global pharmaceutical executive and advisor with over 25 years of experience and is currently an Operating Partner at GHO Capital, a private equity firm specializing in health and life sciences. Prior to GHO Capital, he was Senior Vice President of Global Market Access at Biogen and held global roles at Elan and GlaxoSmithKline.

Tricia D’Cruz is an experienced senior executive, strategy consultant, and entrepreneur. For more than three decades, she has been a leader in growing high-tech companies. Ms. D’Cruz has the distinction of success at both large multi-national public companies and early-stage startup ventures, with extensive experience in mergers and acquisitions.

James Bendle is a versatile finance professional with experience in pre-IPO and large companies. Bendle has led teams in Finance, Investment, Pricing, Treasury, FP&A, M&A analysis, and Reporting functions for companies from startup to Fortune 50. His specialties include FP&A, business planning, modeling, investments, partnerships and scaling operations and systems.